{"transactions":[{"id":888963,"issuer":{"id":7406,"kind":"organization","name":"Context Therapeutics Inc."},"owners":[{"id":65257,"kind":"person","name":"Minai-Azary Jennifer Lynn","position":1,"cik":"0001844398","reported_name":"Minai-Azary Jennifer Lynn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-02-23T16:21:41.000Z","date":"2026-02-19","kind":"grant","planned":false,"acquired":true,"shares":275000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable over a four-year period. Twenty-five percent (25%) of the option vests and becomes exercisable on February 19, 2027, and the balance vests in equal monthly installments over the remaining three years of the four-year period, subject to continued service with the Issuer."}],"balance_after":275000,"derivative":{"exercise_price":2.32,"expiration_date":"2036-02-18","underlying":"Common Stock","underlying_shares":275000},"source":{"system":"sec-edgar","filing":"0001628280-26-010642","document":"wk-form4_1771881698.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1844398/000162828026010642/wk-form4_1771881698.xml","form_type":"4"}},{"id":1116888,"issuer":{"id":7406,"kind":"organization","name":"Context Therapeutics Inc."},"owners":[{"id":65257,"kind":"person","name":"Minai-Azary Jennifer Lynn","position":1,"cik":"0001844398","reported_name":"Minai-Azary Jennifer Lynn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-06-10T17:22:20.000Z","date":"2025-06-06","kind":"purchase","planned":false,"acquired":true,"shares":40010,"price":0.637,"value":25486.37,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported above is a weighted average price. These shares were acquired in several transactions at prices ranging from $0.57 - $0.68. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":80010,"source":{"system":"sec-edgar","filing":"0001842952-25-000060","document":"wk-form4_1749590535.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1844398/000184295225000060/wk-form4_1749590535.xml","form_type":"4"}},{"id":1268210,"issuer":{"id":7406,"kind":"organization","name":"Context Therapeutics Inc."},"owners":[{"id":65257,"kind":"person","name":"Minai-Azary Jennifer Lynn","position":1,"cik":"0001844398","reported_name":"Minai-Azary Jennifer Lynn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-02-14T16:13:21.000Z","date":"2025-02-13","kind":"grant","planned":false,"acquired":true,"shares":371800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable over a four-year period. Twenty-five percent (25%) of the option vests and becomes exercisable on February 13, 2026, and the balance vests in equal monthly installments over the remaining three years of the four-year period, subject to continued service with the Issuer."}],"balance_after":371800,"derivative":{"exercise_price":0.81,"expiration_date":"2035-02-12","underlying":"Common Stock","underlying_shares":371800},"source":{"system":"sec-edgar","filing":"0001842952-25-000022","document":"wk-form4_1739567592.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1844398/000184295225000022/wk-form4_1739567592.xml","form_type":"4"}},{"id":1564114,"issuer":{"id":7406,"kind":"organization","name":"Context Therapeutics Inc."},"owners":[{"id":65257,"kind":"person","name":"Minai-Azary Jennifer Lynn","position":1,"cik":"0001844398","reported_name":"Minai-Azary Jennifer Lynn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2024-03-22T08:04:35.000Z","date":"2024-03-21","kind":"grant","planned":false,"acquired":true,"shares":160115,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable over a four-year period. Twenty-five percent (25%) of the option vests and becomes exercisable on March 21, 2025, and the balance vests in equal monthly installments over the remaining three years of the four-year period, subject to continued service with the Issuer."}],"balance_after":160115,"derivative":{"exercise_price":1.07,"expiration_date":"2034-03-20","underlying":"Common Stock","underlying_shares":160115},"source":{"system":"sec-edgar","filing":"0001842952-24-000019","document":"wk-form4_1711109066.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1844398/000184295224000019/wk-form4_1711109066.xml","form_type":"4"}},{"id":2017626,"issuer":{"id":7406,"kind":"organization","name":"Context Therapeutics Inc."},"owners":[{"id":65257,"kind":"person","name":"Minai-Azary Jennifer Lynn","position":1,"cik":"0001844398","reported_name":"Minai-Azary Jennifer Lynn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-02-14T17:04:29.000Z","date":"2023-02-13","kind":"grant","acquired":true,"shares":158001,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable over a four-year period. Twenty-five percent (25%) of the option vests and becomes exercisable on February 13, 2024, and the balance vests in equal monthly installments over the remaining three years of the four-year period, subject to continued service with the Issuer."}],"balance_after":158001,"derivative":{"exercise_price":0.8407,"expiration_date":"2033-02-12","underlying":"Common Stock","underlying_shares":158001},"source":{"system":"sec-edgar","filing":"0001842952-23-000026","document":"wf-form4_167641222454214.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1844398/000184295223000026/wf-form4_167641222454214.xml","form_type":"4"}},{"id":2082521,"issuer":{"id":7406,"kind":"organization","name":"Context Therapeutics Inc."},"owners":[{"id":65257,"kind":"person","name":"Minai-Azary Jennifer Lynn","position":1,"cik":"0001844398","reported_name":"Minai-Azary Jennifer Lynn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-12-19T16:22:43.000Z","date":"2022-12-16","kind":"purchase","acquired":true,"shares":25000,"price":0.74,"value":18500.0,"ownership":{"direct":true},"balance_after":40000,"source":{"system":"sec-edgar","filing":"0001842952-22-000114","document":"wf-form4_167148450192465.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1844398/000184295222000114/wf-form4_167148450192465.xml","form_type":"4"}},{"id":2182675,"issuer":{"id":7406,"kind":"organization","name":"Context Therapeutics Inc."},"owners":[{"id":65257,"kind":"person","name":"Minai-Azary Jennifer Lynn","position":1,"cik":"0001844398","reported_name":"Minai-Azary Jennifer Lynn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-08-17T17:23:58.000Z","date":"2022-08-17","kind":"purchase","acquired":true,"shares":15000,"price":1.8,"value":27000.0,"ownership":{"direct":true},"balance_after":15000,"source":{"system":"sec-edgar","filing":"0001842952-22-000079","document":"wf-form4_166077142478085.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1844398/000184295222000079/wf-form4_166077142478085.xml","form_type":"4"}},{"id":2372992,"issuer":{"id":7406,"kind":"organization","name":"Context Therapeutics Inc."},"owners":[{"id":65257,"kind":"person","name":"Minai-Azary Jennifer Lynn","position":1,"cik":"0001844398","reported_name":"Minai-Azary Jennifer Lynn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-02-25T16:42:41.000Z","date":"2022-02-25","kind":"grant","acquired":true,"shares":112470,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable over a four-year period. Twenty-five percent (25%) of the option vests and becomes exercisable on February 25, 2023, and the balance vests in equal monthly installments (rounded down to the nearest whole share) over the remaining three years of the four-year period, subject to continued service with the Issuer."}],"balance_after":112470,"derivative":{"exercise_price":1.79,"expiration_date":"2032-02-24","underlying":"Common Stock","underlying_shares":112470},"source":{"system":"sec-edgar","filing":"0001842952-22-000021","document":"wf-form4_164582531007999.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1844398/000184295222000021/wf-form4_164582531007999.xml","form_type":"4"}},{"id":2531074,"issuer":{"id":7406,"kind":"organization","name":"Context Therapeutics Inc."},"owners":[{"id":65257,"kind":"person","name":"Minai-Azary Jennifer Lynn","position":1,"cik":"0001844398","reported_name":"Minai-Azary Jennifer Lynn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-11-01T16:31:17.000Z","date":"2021-11-01","kind":"grant","acquired":true,"shares":52753,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests each month (1/36 each month) from the date of the grant, November 1, 2021"}],"balance_after":52753,"derivative":{"exercise_price":5.59,"expiration_date":"2031-11-01","underlying":"Common Stock","underlying_shares":52753},"source":{"system":"sec-edgar","filing":"0001842952-21-000009","document":"wf-form4_163579861906118.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1844398/000184295221000009/wf-form4_163579861906118.xml","form_type":"4"}},{"id":2822539,"issuer":{"id":7734,"kind":"organization","name":"Tempest Therapeutics, Inc."},"owners":[{"id":65257,"kind":"person","name":"Minai-Azary Jennifer Lynn","position":1,"cik":"0001844398","reported_name":"Minai-Azary Jennifer Lynn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-03-02T17:19:30.000Z","date":"2021-02-26","kind":"grant","acquired":true,"shares":110000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1. Twenty-five percent (25%) of the shares subject to this option shall vest on February 1, 2022, and one thirty-sixth (1/36th) of the remaining shares subject to this option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date. However, all such options, to the extent outstanding immediately prior to a Change in Control (as defined in the 2019 Equity Incentive Plan), will be (or will be deemed to have been) fully vested and exercisable as of immediately prior to such Change in Control."}],"balance_after":110000,"derivative":{"exercise_price":2.06,"expiration_date":"2031-02-25","underlying":"Common Stock","underlying_shares":110000},"source":{"system":"sec-edgar","filing":"0001544227-21-000011","document":"wf-form4_161472352776309.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1844398/000154422721000011/wf-form4_161472352776309.xml","form_type":"4"}}]}